Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial. (Q39285861)
Jump to navigation
Jump to search
scientific article published on 5 May 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial. |
scientific article published on 5 May 2017 |
Statements
Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial (English)
Dong-Wan Kim
Myung-Ju Ahn
Karen L Reckamp
Karin Holmskov Hansen
Sang-We Kim
Rudolf M Huber
Howard L West
Harry J M Groen
Maximilian J Hochmair
Natasha B Leighl
Scott N Gettinger
Corey J Langer
Luis G Paz-Ares RodrÃguez
Egbert F Smit
Edward S Kim
William Reichmann
Frank G Haluska
David Kerstein